If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: FinanzNachrichten
Pasithea Therapeutics: Palatin Technologies Reports Positive Data From Phase 2b BREAKOUT Study
WASHINGTON (dpa-AFX) - Palatin Technologies, Inc. (PTN), Thursday announced positive data from the Phase 2b BREAKOUT study of a melanocortin agonist in patients with diabetic Type 2 nephropathy.Th...
Read full article »
Pasithea Therapeutics's Competitors
|
Pasithea Therapeutics's News
|
Pasithea Therapeutics's Financials
Follow
Followers on Owler
1
Annual Revenue
$100K-5.0M
Employees
1-25
CEO
Tiago Reis Marques
CEO Approval Rating
- -/100
Weigh In
Read more
See Pasithea Therapeutics company profile »
